Mitochondria in health, aging and disease

S. Meiners (München, Germany)

Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Session: Metabolic alterations as a driver of chronicity in lung disease
Session type: Symposium
Number: 1567

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Meiners (München, Germany). Mitochondria in health, aging and disease. International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ageing and the border between health and disease
Source: Eur Respir J 2014; 44: 1332-1352
Year: 2014



The growing chronic disease burden in Europe: a role for respiratory health professionals?
Source: Eur Respir J 2014; 43: 1249-1251
Year: 2014


Mitochondrial dysfunction in lung ageing and disease
Source: Eur Respir Rev, 29 (157) 200165; 10.1183/16000617.0165-2020
Year: 2020



Exercise and respiratory health: improving disease consequences
Source: International Congress 2019 – The future of respiratory diseases: what prevention can do
Year: 2019


Is breathlessness the same in health and disease?
Source: Eur Respir J 2007; 30: Suppl. 51, 125s
Year: 2007

Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes
Source: Eur Respir J, 55 (1) 1900647; 10.1183/13993003.00647-2019
Year: 2020



Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing
Source: Eur Respir J 2014; 44: 1682-1696
Year: 2014



End of life fears in COPD: The influence of biomedical variables, mental health status and disease specific anxieties
Source: Annual Congress 2012 - The best abstracts in chronic care
Year: 2012



Social support and health status in chronic lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 485s
Year: 2001

Recognising advanced disease, advance care planning and recognition of dying for people with COPD
Source: Eur Respir Monogr 2016; 73: 204-220
Year: 2016


Eosinophils and eosinophilic immune dysfunction in health and disease
Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021
Year: 2022



Measuring dyspnoea in health and disease
Source: International Congress 2015 – PG18 Advanced respiratory and cardiovascular testing
Year: 2015




Rehabilitation in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=337
Year: 2006

Survey on health system aspects concerning malignant diseases (lung cancer) in limited health resources country
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008


Microbiome effects on immunity, health and diseases of the lungs
Source: Virtual Congress 2020 – Air pollution and interstitial lung disease: a call to arms
Year: 2020